Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.8 EUR | -0.87% | +6.05% | -14.93% |
May. 15 | BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction | |
May. 15 | Bastide: 8.2% increase in quarterly sales | CF |
Sales 2024 * | 529M 575M | Sales 2025 * | 560M 609M | Capitalization | 170M 185M |
---|---|---|---|---|---|
Net income 2024 * | 16M 17.4M | Net income 2025 * | 22M 23.92M | EV / Sales 2024 * | 0.95 x |
Net Debt 2024 * | 333M 363M | Net Debt 2025 * | 328M 356M | EV / Sales 2025 * | 0.89 x |
P/E ratio 2024 * |
10.1
x | P/E ratio 2025 * |
7.45
x | Employees | 3,635 |
Yield 2024 * |
2.04% | Yield 2025 * |
2.5% | Free-Float | 44.92% |
1 day | -2.17% | ||
1 week | +4.65% | ||
Current month | +25.00% | ||
1 month | +23.63% | ||
3 months | +18.92% | ||
6 months | -5.46% | ||
Current year | -16.04% |
Managers | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Corporate Officer/Principal | 50 | 15-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Vanessa Giraud
BRD | Director/Board Member | 50 | - |
Olivier Mares
BRD | Director/Board Member | 47 | 19-07-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 22.8 | -0.87% | 7 600 |
24-05-27 | 23 | -3.16% | 12,543 |
24-05-24 | 23.75 | +3.71% | 14,803 |
24-05-23 | 22.9 | +3.62% | 16,835 |
24-05-22 | 22.1 | +2.79% | 6,293 |
Real-time Euronext Paris, May 28, 2024 at 05:55 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.04% | 185M | |
+1.23% | 3.14B | |
0.00% | 1.94B | |
+68.75% | 706M | |
-14.59% | 443M | |
-45.44% | 310M | |
-17.25% | 131M | |
+3.85% | 69.16M |
- Stock Market
- Equities
- BLC Stock